NHS England and NHS Improvement have published an update to the guidelines for cancer multi-disciplinary team meetings (MDTM) incorporating every single recommendation from Cancer Research UK’s 2017 publication on the subject, which was co-authored by 2020 Delivery.
- Ensuring adequate time for discussion of cases by allowing more focus on complex cases in the MDTM
- Creating more flexibility in the management of the MDTM
- Agreeing the treatment or care that any patient should expect to receive across cancer alliances
NHSE have confirmed that:
“The key principle to achieve MDTM streamlining is that all patients remain listed and recorded at the MDTM, however patients will be stratified into two groups: Those cases where full discussion at the MDTM is required, for example due to clinical complexity or psycho-social issues, and those cases where a patient’s needs can be met by a standard treatment protocol (or Standard of Care), and so do not require discussion at the MDTM.”
And from CRUK’s perspective: “Thanks again for the brilliant work you and the team did on the report – so pleased to see it having an impact and really proud of what we did.”
Well done, team! One might say that’s 3 years of multi-disciplinary team working!
Here’s hoping that this leads to earlier diagnosis and increased survivorship for those with cancer.